Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer

NCT00601926 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
5
Enrollment
OTHER
Sponsor class

Stopped Poor patient accrual. Attempts to open at other sites unsuccessful.

Conditions

Interventions

Sponsor

Paul Monk

Collaborators